Wire · technology
Ability Neurotech announces first-in-human testing of novel BCI technology
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 July 2026 · Fusion42 review
Ability Neurotech has conducted first-in-human brain-computer interface testing at Munich's TUM University Hospital, capturing high-resolution neural signals during brain tumour surgery under general anaesthetic. The company plans to progress to neural decoding studies with conscious patients performing speech and motor tasks, establishing a foundation for long-term BCI implantation trials.
This Wire brief sits within Fusion42's coverage of Biotech and Medtech, and 2 sources have reported it between 22 Jul 2026 and 29 Jul 2026.
◆ ◆ The Wire takeaway
If you're building sensors, surgical hardware, or data platforms for neurotech, you've just watched a competitor move from lab to patients. Ability has a clinical dataset and a regulatory pathway—that's a 18-month lead on everyone else trying to do this in Europe.
◆ Coverage
2 sources · first reported 22 Jul 2026 · latest 29 Jul 2026
◆ Related on Wire
◆ Topics